2012Zhongguo yaofangRequires access

Efficacy Observation of Penicillamine and Low Dose of Glucocorticoids with Etanercept in the Treatment of Rheumatoid Arthritis

Ying Wang

Open publisher page 0 citations

Abstract

OBJECTIVE:To observe the effectiveness and safety of penicillamine and low dose of glucocorticoids with etanercept(ETA) in the treatment of rheumatoid arthritis(RA).METHODS:56 cases of RA were randomly divided into 2 groups,28 cases in the control group were given daily oral dose of penicillamine 300 mg+prednisone 10 mg once a day,4 weeks later decreasing to 5mg.The experimental group was given enalapril based on control group,subcutaneous injection twice a week,each time 25 mg.The treatment course lasted for 3 months.The therapeutic efficacy was evaluated by American College of Rheumatology(ACR) standard.RESULTS:After 6 and 12 weeks of treatment,the laboratory index and the clinical symptoms of experimental group and control group were improved,the effective rate of 20% improvement of ACR standard(ACR20) were 21.4% and 46.4%,39.3% and 64.3%(P0.05).The changes of disease activity score(DAS28) were compared between 2 groups before and after treatment.Compared with before treatment,DAS28 of patients in the experimental group had decreased significantly at 6 week(P0.05).The most common adverse reactions of experimental group were mainly injection-site reactions,upper respiratory tract infection and gastrointestinal tract reaction;that of control group mainly rash reaction.CONCLUSION:Etanercept is effective and safe in the treatment of RA,can shorten the duration of disease remission.

About this research paper

What this paper is about

OBJECTIVE:To observe the effectiveness and safety of penicillamine and low dose of glucocorticoids with etanercept(ETA) in the treatment of rheumatoid arthritis(RA).METHODS:56 cases of RA were randomly divided into 2 groups,28 cases in the control group were given daily oral dose of penicillamine 300 mg+prednisone 10 mg once a day,4 weeks later decreasing to 5mg.The experimental group was given enalapril based on control group,subcutaneous injection twice a week,each time 25 mg.The treatment course lasted for 3 months.The therapeutic efficacy was evaluated by American College of Rheumatology(ACR) standard.RESULTS:After 6 and 12 weeks of treatment,the laboratory index and the clinical symptoms of experimental group and control group were improved,the effective rate of 20% improvement of ACR standard(ACR20) were 21.4% and 46.4%,39.3% and 64.3%(P0.05).The changes of disease activity score(DAS28) were compared between 2 groups before and after treatment.Compared with before treatment,DAS28 of patients in the experimental group had decreased significantly at 6 week(P0.05).The most common adverse reactions of experimental group were mainly injection-site reactions,upper respiratory tract infection and gastrointestinal tract reaction;that of control group mainly rash reaction.CONCLUSION:Etanercept is effective and safe in the treatment of RA,can shorten the duration of disease remission.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To observe the effectiveness and safety of penicillamine and low dose of glucocorticoids with etanercept(ETA) in the treatment of rheumatoid arthritis(RA).METHODS:56 cases of RA were randomly divided into 2 groups,28 cases in the control group were given daily oral dose of penicillamine 300 mg+prednisone 10 mg once a day,4 weeks later decreasing to 5mg.The experimental group was given enalapril based on control group,subcutaneous injection twice a week,each time 25 mg.The treatment course lasted for 3 months.The therapeutic efficacy was evaluated by American College of Rheumatology(ACR) standard.RESULTS:After 6 and 12 weeks of treatment,the laboratory index and the clinical symptoms of experimental group and control group were improved,the effective rate of 20% improvement of ACR standard(ACR20) were 21.4% and 46.4%,39.3% and 64.3%(P0.05).The changes of disease activity score(DAS28) were compared between 2 groups before and after treatment.Compared with before treatment,DAS28 of patients in the experimental group had decreased significantly at 6 week(P0.05).The most common adverse reactions of experimental group were mainly injection-site reactions,upper respiratory tract infection and gastrointestinal tract reaction;that of control group mainly rash reaction.CONCLUSION:Etanercept is effective and safe in the treatment of RA,can shorten the duration of disease remission.

Key concepts: Medicine, Rheumatoid arthritis, Etanercept, Penicillamine, Internal medicine, Rash, Adverse effect, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy Observation of Penicillamine and Low Dose of Glucocorticoids with Etanercept in the Treatment of Rheumatoid Arthritis — Research Paper | ScholarLens